The Utah Department of Commerce’s Office of Artificial Intelligence Policy approved a pilot that lets August AI manage prescription renewals for people with chronic conditions.
How the pilot works
Founded in 2022, August AI provides a conversational health companion that can answer medical questions, interpret lab results and retain a user’s medication history. The platform is designed to interact in natural language, allowing patients to describe symptoms or ask about dosage without handling complex portals.
In the approved program, the AI will review renewal requests for routine, non-controlled drugs such as those commonly prescribed for diabetes and cardiovascular disease. It then generates a recommendation that is sent to a clinician for final review.
A Utah-licensed physician must examine each AI-generated recommendation before authorizing the prescription, and patients are charged $4 per renewal. This fee covers the technology service, the physician’s time and administrative oversight.
The pilot will advance through drug classes after completing 1,250 physician-reviewed decisions per class and meeting performance benchmarks set by the state. Once those targets are reached, the program may expand to include additional therapeutic areas.
Read Also: Servier partners with Owkin to advance AI-driven cancer research
Regulatory backdrop
Participants must inform patients whenever AI contributes to their care. The company also carries specialty medical malpractice coverage and operates a 24-hour incident-response plan. These safeguards are intended to address any errors that could arise from automated processing.
The agreement was announced at a state press conference that also introduced other health-tech pilots and a new network of independent third-party evaluators. The evaluators include the Coalition for Health AI, Clarion AI Partners, Glacis Technologies, mpathic AI, Vega Health and Stanford Clinical Excellence Research Center.
Utah has been testing AI-driven prescription renewals in a regulatory sandbox. Earlier this year the state partnered with Doctronic to assess autonomous AI renewals for routine medications. After the medical board raised safety concerns, the state declined to suspend the Doctronic pilot because every renewal still required a licensed physician’s review before pharmacy transmission.
“A renewal is one of the simplest things a doctor’s office handles, and it’s also where a lot of patients fall through the cracks,” said Anuruddh Mishra, founder and CEO of August AI. “In this pilot, the AI prepares the renewal and a Utah-licensed physician reviews and authorizes it, with the state overseeing every step. It’s the same standard we hold everywhere at August: physicians make the clinical decisions.”
